BBIO · BridgeBio Pharma, Inc.

$84.12 +0.10 (+0.12%) At close · Jul 27

Market Cap

$16.48B

195.86M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score

84/100

Short interest 13.1% of shares — P93 Days to cover 5.4 — P70 Price vs VWAP +15.2% — P93 Short-volume trend +10.3% — P77 Short interest change +6.8% — P68 Worst FTD 0.87% of shares — P92

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All

Short Interest History

Settlement Date	Current Position	Previous Position	Change	Avg Daily Volume	Days to Cover
2026-08-14 Scheduled FINRA publishes Aug 25	—	—	—	—	—
2026-07-31 Scheduled FINRA publishes Aug 11	—	—	—	—	—
2026-07-15	25,750,649	24,102,938	+1,647,711	4,789,357	5.38
2026-06-30	24,102,938	25,415,150	-1,312,212	5,343,347	4.51
2026-06-15	25,415,150	24,391,359	+1,023,791	2,966,678	8.57
2026-05-29	24,391,359	24,163,037	+228,322	2,541,695	9.60
2026-05-15	24,163,037	24,026,982	+136,055	2,766,467	8.73
2026-04-30	24,026,982	22,676,856	+1,350,126	3,164,946	7.59
2026-04-15	22,676,856	23,366,752	-689,896	1,658,075	13.68
2026-03-31	23,366,752	23,505,637	-138,885	1,586,799	14.73
2026-03-13	23,505,637	21,964,843	+1,540,794	2,627,181	8.95
2026-02-27	21,964,843	21,167,249	+797,594	3,144,750	6.98
2026-02-13	21,167,249	19,980,855	+1,186,394	3,747,599	5.65
2026-01-30	19,980,855	18,370,031	+1,610,824	2,796,641	7.14
2026-01-15	18,370,031	17,211,114	+1,158,917	3,108,552	5.91
2025-12-31	17,211,114	18,793,079	-1,581,965	1,689,124	10.19
2025-12-15	18,793,079	19,381,854	-588,775	1,846,092	10.18
2025-11-28	19,381,854	20,691,850	-1,309,996	2,283,542	8.49
2025-11-14	20,691,850	19,566,757	+1,125,093	2,079,619	9.95
2025-10-31	19,566,757	17,353,906	+2,212,851	2,991,207	6.54
2025-10-15	17,353,906	17,486,250	-132,344	1,972,595	8.80
2025-09-30	17,486,250	19,444,136	-1,957,886	2,428,656	7.20
2025-09-15	19,444,136	19,909,858	-465,722	2,237,940	8.69
2025-08-29	19,909,858	20,486,167	-576,309	2,213,867	8.99
2025-08-15	20,486,167	18,519,082	+1,967,085	3,635,018	5.64
2025-07-31	18,519,082	19,475,283	-956,201	1,951,249	9.49

Showing 1–24 of 24 settlements

Key facts CIK 1743881 CUSIP 10806X102 13F (30d) 85 filings 84 filers Visit website Investor relations